Search Within

Gabriella Bayshtok

Formats
  1. Journal Article (4)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (5)
  2. GSK Faculty (5)
  3. Genitourinary Oncology Service (5)
  4. Human Oncology and Pathogenesis Program (5)
  5. Sarcoma Service (5)
  6. Sloan Kettering Institute Postdocs (5)

More Groups

People
  1. Mohini Pachai (5)
  2. Ping Chi (5)
  3. Yu Chen (5)
  4. Cindy Lee (4)
  5. Dan Li (4)
  6. Naitao Wang (4)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (1)
Publications
  1. Clinical Cancer Research (2)
  2. Cancer Discovery (1)
  3. Journal of Clinical Investigation (1)
  4. Science Advances (1)
Publishers
  1. American Association for Cancer Research (3)
  2. Amer Assoc Advancement Science (1)
  3. American Society for Clinical Investigation (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancer
    Journal Article

    Shukla, S.; Li, D.; Cho, W. H.; Schoeps, D. M.; Nguyen, H. M.; Conner, J. L.; Roskes, M. L.; Tehim, A.; Bayshtok, G.; Pachai, M. R.; more...
    Journal of Clinical Investigation (2025)

    Fulltext@MSK | Save
  • ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer
    Journal Article

    Li, D.; Zhan, Y.; Wang, N.; Tang, F.; Lee, C. J.; Bayshtok, G.; Moore, A. R.; Wong, E. W. P.; Pachai, M. R.; Xie, Y.; more...
    Science Advances (2023)

    Fulltext@MSK | Save
  • PRC2 inactivating mutations amplify cell death in response to DNMT1-targeted therapy through enhanced viral mimicry in malignant peripheral nerve sheath tumor
    Meeting Abstract

    Chi, P.; Patel, A. J.; Warda, S.; Maag, J. L. V.; Misra, R.; Miranda-Román, M. A.; Pachai, M. R.; Lee, C. J.; Li, D.; Wang, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • PRC2-inactivating mutations in cancer enhance cytotoxic response to DNMT1-targeted therapy via enhanced viral mimicry
    Journal Article

    Patel, A. J.; Warda, S.; Maag, J. L. V.; Misra, R.; Miranda-Román, M. A.; Pachai, M. R.; Lee, C. J.; Li, D.; Wang, N.; Bayshtok, G.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Combined inhibition of Gα(q) and MEK enhances therapeutic efficacy in uveal melanoma
    Journal Article

    Hitchman, T. D.; Bayshtok, G.; Ceraudo, E.; Moore, A. R.; Lee, C.; Jia, R.; Wang, N.; Pachai, M. R.; Shoushtari, A. N.; Francis, J. H.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save